SI
REPL icon

Sofinnova Investments’s Replimune Group REPL Stock Holding History

Sofinnova Investments’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.77M Buy
+1,015,400
New +$7.76M 0.3% 51
2023
Q4 		– Sell
-250,000
Closed -$4.28M – 73
2023
Q3 		$4.28M Buy
+250,000
New +$4.91M 0.27% 49

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sofinnova Investments's REPL Position: Q3 2025 in Review

Sofinnova Investments sold out of Replimune Group (REPL) in Q3 2025, closing a stake of 1,806,529 shares — an estimated $16.8M sold.

Sofinnova Investments first reported a position in REPL in Q4 2020 and held it in 9 quarters. The position peaked at $38.1M in Q4 2024. 163 funds tracked by Wall St. Rank hold REPL as of Q3 2025.

  • Sofinnova Investments reported no remaining Replimune Group position as of Q3 2025 after selling out during the quarter.
  • Sofinnova Investments sold 1,806,529 Replimune Group shares in Q3 2025, an estimated $16.8M.
  • Sofinnova Investments first reported a position in Replimune Group in Q4 2020 and held it in 9 quarters.
  • Sofinnova Investments's Replimune Group position peaked at $38.1M in Q4 2024.
  • 163 funds tracked by Wall St. Rank held Replimune Group as of Q3 2025.

Based on Sofinnova Investments's 13F filing for Q3 2025, filed 14 Nov 2025.